Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Kara Beasley

Neurological Surgery Boulder, CO Doctor of Osteopathy

NPI 1255588190 CMS profile 56701

4743 Arapahoe Ave, Suite 202, Boulder, CO 80303

Open in the dashboard

General payments

$30,289

156 records reported · program years 2019–2025

Research payments

$2,800

Paid to them · 2 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Kara Beasley of Boulder, CO is reported in the CMS Open Payments database as having received $30,289 across 156 general payments and $2,800 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 83rd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $8,520 17
2024 General $5,337 17
2023 General $589 16
2023 Research $2,200 1
2022 General $1,598 20
2022 Research $600 1
2021 General $346 11
2020 General $1,948 19
2019 General $11,951 56

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Kara Beasley
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Kara Beasley were reported at $8,520. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Kara Beasley Neurological Surgery median Middle half National median
2019 $11,951 $582 $138–$3,006 $163
2020 $1,948 $294 $76–$2,174 $114
2021 $346 $387 $105–$2,432 $132
2022 $1,598 $542 $139–$2,989 $149
2023 $589 $534 $145–$2,697 $160
2024 $5,337 $574 $155–$3,046 $164
2025 $8,520 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $23,683 48 payments
  2. Medtronic USA, Inc. $2,887 54 payments
  3. InSightec,Inc $2,174 8 payments
  4. Medtronic, Inc. $1,055 34 payments
  5. Penumbra, Inc. $145 1 payment
  6. Camber Spine Technologies $77 1 payment
  7. DePuy Synthes Sales Inc. $76 2 payments
  8. Cerapedics, Inc. $40 2 payments
  9. Alphatec Spine, Inc $35 1 payment
  10. Abbott Laboratories $31 1 payment
  11. Other $87 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $12,925 16 payments
  2. Consulting Fee $8,125 1 payment
  3. Food and Beverage $5,188 125 payments
  4. Travel and Lodging $4,051 14 payments
Products named General payments · program years 2019–2025
  1. SPECTRA WAVEWRITER $8,791 5 payments
  2. General - DBS $8,450 14 payments
  3. ACTIVA $1,368 14 payments
  4. EXABLATE $1,164 6 payments
  5. GENERAL THERAPIES $764 4 payments
  6. MazorX - Renaissance $718 8 payments
  7. OSTEOCOOL RF ABLATION SYSTEM $567 14 payments
  8. PIVOX Oblique Lateral Spinal System $305 3 payments
  9. Penumbra System $290 2 payments
  10. GENERAL DBS $266 3 payments
  11. Other $1,711 70 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Functional Neuromodulation Inc $2,800 2 payments

Billing to Medicare

Part B · data year 2024 · 49 billing codes

Paid by Medicare

$62,040

Medicare's payments for the services billed

Medicare patients

123

Average age 76

Services billed

212

67 women, 56 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 72%
Depression 42%
Ischemic heart disease 36%
Diabetes 24%
Heart failure 24%
Cancer 23%
Osteoporosis 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

158 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record